Learning Objectives
At the conclusion of this activity, participants should be better able to:
- Recognize when ovarian suppression is appropriate to aid the treatment of breast cancer
- Review the general mechanism of action for antibody-drug conjugates (ADCs) in breast cancer
Faculty
Rebecca A. Shatsky, MD Associate Professor of Medicine
Scientific Director Inflammatory and
Triple Negative Breast Cancer Program
UC San Diego School of Medicine
San Diego, California
Accreditation
The Annenberg Center for Health Sciences at Eisenhower designates
this live activity for a maximum of
1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation
in the activity.
Provider is approved by the California Board of Registered Nursing, Provider #13664, for 1 contact hour.
To receive credit for education contact hours outside of the state of California, please check with your state board of registered nursing for reciprocity.
Disclosure Statement
It is the policy of the Annenberg Center for Health Sciences to ensure fair balance,
independence, objectivity, and scientific rigor in all programming. All individuals with the
potential to impact the content of an accredited education activity are expected to identify and
reference off-label product use and disclose relationships with ACCME-defined ineligible
companies.
The Annenberg Center for Health Sciences assesses relevant relationships with its instructors,
planners, managers, and other individuals who are in a position to control the content of CE
activities. All relevant relationships that are identified are thoroughly vetted by the
Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity,
and patient care recommendations. The Annenberg Center is committed to providing its learners
with high-quality CE activities and related materials that promote improvements or quality
in healthcare and not a specific proprietary business interest of a commercial interest.
In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel
documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the
following disclosures have been made:
Disclosures
Rebecca A. Shatsky, MD Advisory Board: OncoSec
Consultant: AstraZeneca, Quantum Leap
Research Support: Genentech/Roche, OBI Pharma, OncoSec, Oncternal, Phoenix Molecular Designs
The faculty for this live activity has disclosed that there will be
no
discussion about the use of products for non-FDA approved applications.
Annenberg Center for Health Sciences
All members of the Eisenhower Health Education Committee have no relevant financial relationships
to
disclose
All of the financial relationships listed for these individuals have been mitigated.
The ideas and opinions presented in this educational activity are those of the faculty and do not
necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational
activities, we encourage practitioners to use their own judgment in treating and addressing the
needs of each individual patient, taking into account that patient's unique clinical situation.
The Annenberg Center disclaims all liability and cannot be held responsible for any problems
that may arise from participating in this activity or following treatment recommendations
presented.
Our Policy on Privacy
Annenberg Center for Health Sciences respects your privacy. We don’t share information you
give us, or have the need to share this information in the normal course of providing the
services and information you may request. If there should be a need or request to share this
information, we will do so only with your explicit permission. See Privacy Statement and other
information at https://annenberg.net/pages/privacyPolicy.php
Contact Information
Annenberg Center for Health Sciences
39000 Bob Hope Drive
Dinah Shore Building
Rancho Mirage, CA 92270
ce@annenberg.net
Phone: 760-773-4500
Fax: 760-773-4513
8 AM – 5 PM,
Pacific Time, Monday – Friday
